Janux Therapeutics, Inc. (JANX)
14.51
+0.61
(+4.39%)
USD |
NASDAQ |
Apr 01, 16:00
14.49
-0.02
(-0.14%)
After-Hours: 20:00
Janux Therapeutics Research and Development Expense (TTM) : 125.90M for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Bristol Myers Squibb Co. | 9.492B |
| Merck & Co., Inc. | 12.71B |
| EyePoint Plc | 221.04M |
| CorMedix, Inc. | 19.33M |
| Viking Therapeutics, Inc. | 344.96M |